Urinary Tract Infections
Background
Urinary tract infections (UTIs) can be classified into lower, upper (i.e. pyelonephritis) and catheter associated UTIs. Antibiotic management differs for each class and between men, non-pregnant women and in pregnancy. Initial investigations and additional management do not differ between groups. Initial investigations include obtaining a urine sample for urine dipstick and laboratory microscopy, culture and sensitivities. Additional management includes pain relief and ensuring the intake of sufficient fluids. There has been no evidence found for cranberry products or urine alkalinising agents to treat lower UTIs. All antibiotics should be reviewed when sensitivities are available, adjusting if resistance is present.
Asymptomatic bacteriuria is significant levels of bacteria in urine with no UTI symptoms. It is not screened for or treated in non-pregnant women, men, children or young people. For pregnant people, it is screened for and treated as it is a risk factor for pyelonephritis and premature delivery.
Catheter-Associated UTI
Catheter-associated UTI is a symptomatic infection of the bladder or kidneys in a person with a urinary catheter. Antibiotic prophylaxis to prevent catheter-associated UTIs is not recommended. Asymptomatic bacteriuria is common in people with catheters. It can be found in almost all catheterised people one month after catheterisation. It, therefore, does not need to be treated if asymptomatic.
Management
- Remove, or if not possible, change the catheter if it has been in situ for less than 7 days.
- Give oral antibiotics as a first-line if people can take oral medicines and the severity of their condition does not require intravenous antibiotics.
- Give IV antibiotics if vomiting, unable to take oral antibiotics or severely unwell. Review intravenous antibiotics within 48 hours and consider stepping down to oral antibiotics where possible
Upper UTI
| First line | Second line | |
|---|---|---|
| Non-pregnant women and men | Oral – Nitrofurantoin MR 100mg BD for 7 days OR Trimethoprim 200mg BD for 7 days
IV – Ceftriaxone 1 to 2g OD or ciprofloxacin 400mg BD/TDS OR Co-amoxiclav 1.2g TDS in culture showing sensitivity |
Oral – Pivmecillinam (a penicillin) 400 mg initial dose, then 200 mg three times a day for a total of 7 days
IV – consult local microbiologist |
| In pregnancy | Oral – Cefalexin 500mg BD/TDS for 7 to 10 days
IV – cefuroxime 750mg to 1.5g TDS/QDS |
Consult local microbiologist |
| Has upper UTI symptoms | Cefalexin 500 mg BD/TDS for 7 to 10 days
OR Co-amoxiclav (only if culture shows susceptibility) 500/125 mg TDS for 7 to 10 days OR Trimethoprim (only if culture shows susceptibility) 200 mg BD for 14 days |
Consult local microbiologist |
Lower UTI
Lower UTI (cystitis) is a bladder infection usually caused by bacteria travelling up to the urethra from the gastrointestinal tract. Management involves antibiotics and symptomatic management as described in ‘Background’.
| First line | Second line (no symptomatic improvement on first line for at least 48 hours) | |
|---|---|---|
| Non-pregnant women | Nitrofurantoin MR 100 mg BD for 3 days (use only if eGFR ≥45)
OR Trimethoprim 200 mg twice a day for 3 days |
Pivmecillinam (a penicillin) 400 mg initial dose, then 200 mg three times a day for a total of 3 days |
| Men | Nitrofurantoin MR 100 mg BD for 7 days (use only if eGFR ≥45)
OR Trimethoprim 200 mg twice a day for 7 days |
Consider alternative diagnoses such as pyelonephritis and prostatitis
Change antibiotic to culture and sensitivity results |
| In pregnancy | Nitrofurantoin MR 100 mg twice a day for 7 days (avoid at term) | Cefalexin 500mg BD 7 days
OR Amoxicillin 500mg TDS for 7 days if culture results show susceptibility |
References
- National Institute for Health Care Excellence. Urinary tract infection (lower): antimicrobial prescribing. London: NICE; 2018.(NICE Guideline No. 109). Available from: https://www.nice.org.uk/guidance/ng109
- National Institute for Health Care Excellence. Urinary tract infection (catheter associated): antimicrobial prescribing. London: NICE; 2018.(NICE Guideline No. 113). Available from: https://www.nice.org.uk/guidance/ng113
- National Institute for Health Care Excellence. Urinary tract infections in adults. London: NICE; 2015. (NICE Guideline No. qs90). Available from: https://www.nice.org.uk/guidance/qs90
Take your subscriptions with you
Our mobile app allows you to access your interview and exam question banks wherever you are.